ARPHA OAI-PMH Endpoint
metadata only
CC BY 4.0
Animal study of the cardiovascular effects of tofacitinib: Hemodynamic, biochemical, vascular, and mortality outcomes
Tofacitinib has raised cardiovascular safety concerns despite its proven therapeutic value in inflammatory diseases. This study evaluated its preclinical cardiovascular effects in a mouse model after 28 days of treatment with three different doses. Tofacitinib induced dose-dependent reductions in sy
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Phase 1 Study To Evaluate The Pharmacokinetics (PK), Safety, And Bioavailability Of A Modified-Release (MR) Formulation Of Tofacitinib In Healthy Volunteers#909222
- Tofacitinib in Hospitalized Patients With COVID-19 Pneumonia#912618
- Real-life Experience of Tofacitinib in Patients With Treatment-Resistant Rheumatoid Arthritis#1075367
- Study to Evaluate the Effect of Multiple-Dose Ritlecitinib on the Pharmacokinetics (PK) of Tolbutamide#1152869
- TOFAcitinib in SARS-CoV2 Pneumonia#1163298
Record · ID 1056010
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive